133 results
8-K
EX-10.1
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
, including, without limitation, a negative assurance letter addressed to the Placement Agent and in form and substance satisfactory to the Placement
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i
424B4
APVO
Aptevo Therapeutics Inc
12 Apr 24
Prospectus supplement with pricing info
5:23pm
. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus … , the market value of the Common Warrants and Pre-funded Warrants is uncertain and there can be no assurance that the market value of the Common Warrants
DEFR14A
8qbbd cyao
16 Jan 24
Revised proxy
4:15pm
8-K
9vjwol8h p9
15 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm